Different biomarkers seem to predict histological transformation, from NSCLC to SCLC tumors, such as loss of EGFR mutations, inactivated mutation of TP53, inactivated mutation of RB1, and activating mutation of PI3KCA genes [117,118,177,178]. The gene discussed is RB1; the disease is non-small cell lung carcinoma.